Search research articles
Contact Us
Filters
Showing results (101-110 of 157) with videos related to
Page
of 16
Sort By:
Kidney International
|
April 16, 2009
Autosomal recessive Bardet-Biedl syndrome: first-degree relatives have no predisposition to metabolic and renal disorders
Michael P Webb, Elizabeth L Dicks, Jane S Green, et al.
American Journal of Nephrology
|
November 30, 2022
Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials
Rajiv Agarwal, Sanjeev Anand, Kai-Uwe Eckardt, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
September 6, 2017
Inflammatory diet and risk for colorectal cancer: A population-based case-control study in Newfoundland, Canada
Ishor Sharma, Yun Zhu, Jennifer R Woodrow, et al.
Hereditary Cancer in Clinical Practice
|
September 9, 2011
Lynch syndrome: barriers to and facilitators of screening and disease management
Kathy E Watkins, Christine Y Way, Jacqueline J Fiander, et al.
Anticancer Research
|
January 31, 2012
Reported intake of selected micronutrients and risk of colorectal cancer: results from a large population-based case-control study in Newfoundland, Labrador and Ontario, Canada
Zhuoyu Sun, Yun Zhu, Peizhong Peter Wang, et al.
Nutrition and Cancer
|
September 13, 2012
Vitamin D intake is negatively associated with promoter methylation of the Wnt antagonist gene DKK1 in a large group of colorectal cancer patients
James B Rawson, Zhouyu Sun, Elizabeth Dicks, et al.
Heart Rhythm
|
March 3, 2020
Exercise and arrhythmic risk in TMEM43 p.S358L arrhythmogenic right ventricular cardiomyopathy
Frédéric L Paulin, Kathleen A Hodgkinson, Sarah MacLaughlan, et al.
Kidney Medicine
|
July 10, 2023
Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non<b>-</b>Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO<sub>2</sub>TECT Randomized Clinical Trial of ESA-Treated Patients
Patrick S Parfrey, Steven K Burke, Glenn M Chertow, et al.
Carcinogenesis
|
October 19, 2007
MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancer
Miralem Mrkonjic, Stavroula Raptis, Roger C Green, et al.
Journal of the American College of Cardiology
|
February 1, 2005
The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)
Kathy A Hodgkinson, Patrick S Parfrey, Anne S Bassett, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 157) with videos related to
Sort By:
Page
of 16
Kidney International
|
April 16, 2009
Autosomal recessive Bardet-Biedl syndrome: first-degree relatives have no predisposition to metabolic and renal disorders
Michael P Webb, Elizabeth L Dicks, Jane S Green, et al.
American Journal of Nephrology
|
November 30, 2022
Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials
Rajiv Agarwal, Sanjeev Anand, Kai-Uwe Eckardt, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
September 6, 2017
Inflammatory diet and risk for colorectal cancer: A population-based case-control study in Newfoundland, Canada
Ishor Sharma, Yun Zhu, Jennifer R Woodrow, et al.
Hereditary Cancer in Clinical Practice
|
September 9, 2011
Lynch syndrome: barriers to and facilitators of screening and disease management
Kathy E Watkins, Christine Y Way, Jacqueline J Fiander, et al.
Anticancer Research
|
January 31, 2012
Reported intake of selected micronutrients and risk of colorectal cancer: results from a large population-based case-control study in Newfoundland, Labrador and Ontario, Canada
Zhuoyu Sun, Yun Zhu, Peizhong Peter Wang, et al.
Nutrition and Cancer
|
September 13, 2012
Vitamin D intake is negatively associated with promoter methylation of the Wnt antagonist gene DKK1 in a large group of colorectal cancer patients
James B Rawson, Zhouyu Sun, Elizabeth Dicks, et al.
Heart Rhythm
|
March 3, 2020
Exercise and arrhythmic risk in TMEM43 p.S358L arrhythmogenic right ventricular cardiomyopathy
Frédéric L Paulin, Kathleen A Hodgkinson, Sarah MacLaughlan, et al.
Kidney Medicine
|
July 10, 2023
Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non<b>-</b>Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO<sub>2</sub>TECT Randomized Clinical Trial of ESA-Treated Patients
Patrick S Parfrey, Steven K Burke, Glenn M Chertow, et al.
Carcinogenesis
|
October 19, 2007
MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancer
Miralem Mrkonjic, Stavroula Raptis, Roger C Green, et al.
Journal of the American College of Cardiology
|
February 1, 2005
The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)
Kathy A Hodgkinson, Patrick S Parfrey, Anne S Bassett, et al.
Page
of 16